Your browser doesn't support javascript.
SARS-CoV-2 antibody prevalence among healthcare workers: A cross-sectional study at a quaternary healthcare center in Saudi Arabia.
Amer, Hala A; Abdallah, Hassan A; Alkheledan, Haifa S; Alzarzour, Shaimaa H; Shrahily, Ahmad; Tamim, Hani; Alqahtani, Saleh A; Memish, Ziad A.
  • Amer HA; Prevention and Control of Infection Administration, King Saud Medical City, Riyadh, Saudi Arabia; Community Medicine Research Department, National Research Center, Egypt.
  • Abdallah HA; Prevention and Control of Infection Administration, King Saud Medical City, Riyadh, Saudi Arabia.
  • Alkheledan HS; Prevention and Control of Infection Administration, King Saud Medical City, Riyadh, Saudi Arabia.
  • Alzarzour SH; Prevention and Control of Infection Administration, King Saud Medical City, Riyadh, Saudi Arabia.
  • Shrahily A; Prevention and Control of Infection Administration, King Saud Medical City, Riyadh, Saudi Arabia.
  • Tamim H; Biostatistics Unit, Clinical Research Institute, American University of Beirut, Medical Center, Beirut, Lebanon.
  • Alqahtani SA; Liver Transplantation Unit, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia & Department of Medicine, The Johns Hopkins University, Hospital, Baltimore, Maryland, USA.
  • Memish ZA; Research and Innovation Center, King Saud Medical City & College of Medicine, AlFaisal University, Riyadh, Saudi Arabia & Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: zmemish@yahoo.com.
J Infect Public Health ; 15(3): 343-348, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1734755
ABSTRACT

BACKGROUND:

The objective of this study was to determine the seroprevalence of SARS-CoV-2 antibodies among Healthcare Workers (HCWs).

METHODS:

We carried out a cross-sectional study among 3644 HCWs at King Saud Medical City (KSMC) during the last two weeks of December 2020. A Google form survey was used to collect data on demographics, underlying health conditions, job duties, infection control competencies, COVID-19 exposure history, symptoms, and confirmed infections.

FINDINGS:

26.5% demonstrated seropositivity to SARS-CoV-2 antibodies, 10-fold higher than the national seroprevalence (2.36) conducted in May 2020. Seropositivity was significantly higher among non-Saudi HCWs and participants who lived outside the hospital dormitory p < 0.0001 and 0.01, respectively). Seropositivity was significantly higher among HCWs who worked on clinical areas of high exposure level, and those who spent longer duration working with patients with COVID-19; p = 0.002 and 0.005, respectively).

CONCLUSION:

SARS-CoV-2 infections among HCWs can go unrecognized, which magnifies the importance of complying with universal masking and social distancing directives. Detecting SARS-CoV-2 antibodies in HCWs can help healthcare leaders in considering staff allocations and assignments accordingly.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2022 Document Type: Article Affiliation country: J.jiph.2022.01.018

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2022 Document Type: Article Affiliation country: J.jiph.2022.01.018